Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare urticaria lesions (size, kinetics) by thermography,
volumetry and digital time lapse photography in CU patients treated with desloratadine 5 mg
or desloratadine 20 mg. Hypothesis: Updosing of desloratadine (20mg) is more efficient in the
treatment of urticarial lesions as compared to standard dosing (5 mg desloratadine).